V
Vedere Bio
0 followers
Vedere Bio II, Inc.® is a company developing next generation ocular gene therapies designed for vision restoration and preservation for patients with vision loss due to photoreceptor death.
Org chart
Daniel Zimmer
Senior Director, Program Lead
Ellen Zyrkowski
Associate Director, HR & Communications
Soraya Bekkali, MD
Non Executive Director
Xiaozhi Ren (任小峙) Ph.D.
Director, CMC, Cell Line and Process Development
Karen Guerin
Senior Director, Discovery Research
Board & advisors
John Flannery
Scientific Founder
Ehud Isacoff
Scientific Founder
Similar companies
Vaxcyte
2 followers
Vera Therapeutics
2 followers
Day One Biopharmaceuticals
1 follower
Cardurion Pharmaceuticals
1 follower
Metagenomi
3 followers
Gilead Sciences
139 followers
Biogen
124 followers
Regeneron
106 followers
Illumina
73 followers
Myriad Genetics
38 followers
Alexion Pharmaceuticals
35 followers
Explore companies